Unrelated Cord Blood Transplantation for Patients with Primary or Secondary Myelofibrosis

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 11, 2014, Pages 1841-1846

  Robin, Marie ^a   Giannotti, Federica ^a   Deconinck, Eric ^b   Mohty, Mohamad ^c   Michallet, Mauricette ^d   Sanz, Guillermo ^e   Chevallier, Patrice ^f   Cahn, Jean Yves ^g   Legrand, Faezeh ^h   Rovira, Montserrat ⁱ   Passweg, Jakob ^j   Sierra, Jorge ^k   Nguyen, Stephanie ^l   Maillard, Natacha ^m   Yakoub Agha, Ibrahim ⁿ   Linkesch, Werner ^o   Cannell, Paul ^p   Marcatti, Magda ^q   Bay, Jacques Olivier ^r   Chalandon, Yves ^s   Kröger, Nicolaus ^t   Gluckman, Eliane ^a,u   Rocha, Vanderson ^u,v   Olavarria, Eduardo ^w   Ruggeri, Annalisa ^a,c   more..

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY HOSPITAL OF NICE   (France)

ⁱ INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^j UNIVERSITY HOSPITAL BASEL   (Switzerland)

^k HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^l PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^m POITIERS UNIVERSITY HOSPITAL   (France)

ⁿ LILLE UNIVERSITY HOSPITAL   (France)

^o MEDICAL UNIVERSITY OF GRAZ   (Austria)

^p ROYAL PERTH HOSPITAL   (Australia)

^q SAN RAFFAELE HOSPITAL   (Italy)

^r HÔTEL DIEU   (France)

^s GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^t UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^u CENTRE SCIENTIFIQUE DE MONACO   (Monaco)

^v OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^w Instituto de Investigación Sanitaria de Navarra   (Spain)

more..

Author keywords

Myelofibrosis; Umbilical cord blood transplantation

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE ASSOCIATION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; MALIGNANT TRANSFORMATION; MIDDLE AGED; MYELOFIBROSIS; MYELOID METAPLASIA; NEUTROPHIL; OVERALL SURVIVAL; REDUCED INTENSITY CONDITIONING; SECONDARY MYELOFIBROSIS; THROMBOCYTE; TREATMENT OUTCOME; UNRELATED DONORS; WHOLE BODY RADIATION; ADVERSE EFFECTS; FETUS BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; PRIMARY MYELOFIBROSIS; PROCEDURES;

CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PRIMARY MYELOFIBROSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; UNRELATED DONORS;

EID: 84908069791     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.06.011     Document Type: Article

References (18)

1. Robin M., Tabrizi R., Mohty M., et al. Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC). Br J Haematol 2011, 152:331-339.
2. Deeg H.J., Appelbaum F.R. Indications for and current results with allogeneic hematopoietic cell transplantation in patients with myelofibrosis. Blood 2011, 117:7185.
3. Ballen K.K., Shrestha S., Sobocinski K.A., et al. Outcome of transplantation for myelofibrosis. Biol Blood Marrow Transplant 2010, 16:358-367.
4. Patriarca F., Bacigalupo A., Sperotto A., et al. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Haematologica 2008, 93:1514-1522.
5. Scott B.L., Gooley T.A., Sorror M.L., et al. The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation. Blood 2012, 119:2657-2664.
6. Kroger N., Holler E., Kobbe G., et al. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: aprospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood 2009, 114:5264-5270.
7. Rondelli D., Barosi G., Bacigalupo A., et al. Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia. Blood 2005, 105:4115-4119.
8. Alchalby H., Yunus D.R., Zabelina T., et al. Risk models predicting survival after reduced-intensity transplantation for myelofibrosis. Br J Haematol 2012, 157:75-85.
9. Samuelson S., Sandmaier B.M., Heslop H.E., et al. Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age. Br J Haematol 2011, 153:76-82.
10. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. NEngl J Med 2004, 351:2276-2285.
11. Eapen M., Rubinstein P., Zhang M.J., et al. Outcomes of transplantation ofunrelated donor umbilical cord blood and bone marrow in childrenwith acute leukaemia: a comparison study. Lancet 2007, 369:1947-1954.
12. Brunstein C.G., Gutman J.A., Weisdorf D.J., et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 2010, 116:4693-4699.
13. Takagi S., Ota Y., Uchida N., et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis. Blood 2010, 116:649-652.
14. Murata M., Nishida T., Taniguchi S., et al. Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT. Bone Marrow Transplant 2014, 49:355-360.
15. Mesa R.A., Li C.Y., Ketterling R.P., et al. Leukemic transformation inmyelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood 2005, 105:973-977.
16. Dupriez B., Morel P., Demory J.L., et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 1996, 88:1013-1018.
17. Passamonti F., Cervantes F., Vannucchi A.M., et al. Adynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 2010, 115:1703-1708.
18. Thiele J., Kvasnicka H.M. Hematopathologic findings in chronic idiopathic myelofibrosis. Semin Oncol 2005, 32:380-394.